Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy-Reference-Cited by-同舟云学术

Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy

Published:2020-02 Issue:2 Volume:95 Page:306-318
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Vasmatzis George^ORCID,Liu Minetta C.,Reganti Sowjanya,Feathers Ryan W.,Smadbeck James,Johnson Sarah H.,Schaefer Klein Janet L.,Harris Faye R.,Yang Lin,Kosari Farhad,Murphy Stephen J.,Borad Mitesh J.^ORCID,Thompson E. Aubrey,Cheville John C.,Anastasiadis Panos Z.

Funder

Mayo Clinic

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas;Boland;Hum Pathol,2009

3. Molecular pathology of lung cancer: current status and perspectives;Oberndorfer;Curr Opin Oncol,2018

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. HER-2/neu oncogene amplification and expression in breast and ovarian cancers;Press;Prog Clin Biol Res,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model;Frontiers in Immunology;2024-03-28

2. Effects of psychological stress on the emission of volatile organic compounds from the skin;Scientific Reports;2024-03-27

3. Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation;Scientific Reports;2024-03-27

4. Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions;Cell Reports Medicine;2024-02

5. Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2;Frontiers in Molecular Biosciences;2022-08-23